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Abstract 
 
 
Stroke is the 3rd cause of death in the world. During stroke, there is a disruption in the blood 
supply to the brain leading to rapid loss of brain function. Ischemic strokes are caused by 
obstruction of the blood supply, while hemorrhagic strokes results from rupture of a blood 
vessel. Eight-five percent of the strokes are ischemic. The only treatment recommended for 
acute ischemic stroke is the recombinant tissue activator of plasminogen but only a few 
percentages of patients are eligible for rtPA administration. Approximately 30% of the 
ischemic stroke victims die and 30% become severely disabled, resulting in among others 
deficits in motor function in the contralateral musculature.  
Spontaneous recovery occurs during weeks to months following injury. There are many 
physiological and anatomical examples of cortical brain plasticity and one of the most potent 
modulators of cortical structure and function is behavioral experience. Functional recovery 
after stroke can be enhanced by physical training in stroke patients. In the animal settings, 
physical training can be accomplished by enriched environment (EE). EE refers to housing 
conditions, either home cages or exploratory chamber, that facilitate enhanced sensory, 
cognitive and motor stimulation relative to standard housing conditions. 
The extracellular matrix (ECM) is important in the regulation of brain plasticity but is also a 
potential hampering factor for recovery after stroke. It is known that EE affects chondroitin 
sulfate proteoglycans (CSPGs) present in ECM, leading to functional recovery. Matrix 
metalloproteinases (MMPs) are able to cleave ECM components. There are some evidences 
that beta-dystroglycan (β-DG) is a MMP-9 target. After the degradation of β-DG, there is a 30 
kDa product.  
The aim of this work is to explore how EE affects β-DG and gelatinases over 1 week of 
recovery after experimental stroke, performed as photothrombosis (PT). We show that EE 
does not affect the infarct size and improves tactile/proprioceptive response to limb 
stimulation. We found that β-DG is mostly present in vessels across the brain cortex and 
animals housed in an EE had a higher degradation than STD animals when comparing to 
sham non-operated animals.  
β-DG can be related with changes in the ECM that leads to brain plasticity, promoting 
functional recovery after experimental stroke, possibly due to MMPs enzymatic activity. 
 
Keywords: ischemic stroke, infarct, photothrombosis, enriched environment, extracellular 
matrix, matrix metalloproteinases, beta-dystroglycan  
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Resumo 
 
 
O Acidente Vascular Cerebral (AVC) consta como a terceira causa de morte no Mundo e a 
primeira em Portugal. Num AVC, uma disrupção no fluxo sanguíneo no cérebro leva a uma 
rápida perda da função cerebral. Os AVCs podem ser qualificados em isquémicos ou 
hemorrágicos. Os AVCs isquémicos são causados por uma obstrução no fluxo sanguíneo, 
enquanto que os AVCs hemorrágicos são causados por uma ruptura do vaso sanguíneo. 
Cerca de 85% dos AVCs são isquémicos. O único tratamento recomendado para a fase 
aguda do AVC isquémico é o ativador plasminogénio tecidual recombinante (rtPA) mas 
apenas uma pequena percentagem de pacientes é elegível para a administração de rtPA. 
Sendo que maioria dos pacientes não chegam nas primeiras 4,5 horas do AVC, após esse 
intervalo de tempo para o tratamento não há nenhum tratamento alternativo. Existem vários 
fatores de risco para o AVC, inclusive hipertensão arterial e aterosclerose que normalmente 
advém de obesidade. Ainda a base genética é conhecida como um importante fator de risco, 
como por exemplo, polimorfismos e mutações em genes que regulam a tensão arterial e a 
fibrilação nos vasos.  
As vítimas do AVC isquémico podem morrer ou ficar severamente inválidos. O AVC leva a 
deficits na função motora da musculatura contralateral à lesão cerebral. Porém, recuperação 
espontânea pode ocorrer nas semanas a meses após a lesão. Há vários exemplos 
fisiológicos e anatómicos de plasticidade no córtex cerebral e um dos maiores moduladores 
da estrutura e função cortical é a experiência comportamental de cada paciente.  
Assim, a recuperação funcional após AVC pode ser aumentada através de um treino físico 
em pacientes com AVC. Em experimentos animais, o treino físico é chamado de 
“enriquecimento ambiental” (enriched environment: EE). EE refere-se a condições 
habitacionais, quer em gaiolas que em câmara exploratórias, que facilitam o melhoramento 
sensorial, cognitivo e estimulação motora relativamente a condições habitacionais standard. 
A matriz extracelular é importante na regulação da neuroplasticidade mas também é um 
factor que poderá potencialmente impedir a recuperação após o AVC. Visto que a matriz 
extracelular a estabilizar EE afecta proteoglicanos de sulfatos de condroitina (CSPGs) que 
se encontram na ECM. A diferença encontrada nestes proteoglicanos ajuda na recuperação 
funcional cerebral. Apesar de não se saber que proteína poderá ajudar nesta situação, sabe-
se que metaloproteinases da matriz são enzimas que têm a capacidade de clivar 
componentes da matriz extracelular. Existem evidências que beta-distroglicano, que faz 
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parte do complexo distroglicano, é um substrato alvo de MMP-9. Após a degradação de β-
DG, obtém-se um produto de 30 kDa.  
O objetivo desta tese tem como observar se EE afecta β-DG durante uma semana de 
recuperação após AVC experimental, neste caso, foi usado uma técnica chamada 
fototrombose. 
Neste estudo, mostramos que EE não afecta o tamanho do enfarte e que melhor a resposta 
táctil/propriocetiva após estimulação dos membros afetados. Vimos ainda que β-DG está 
maioritariamente presente em vasos sanguíneos no córtex cerebral. Animais em gaiolas EE 
tiveram uma maior degradação de beta-distroglicano do que animais STD quando 
comparando com animais sham não operados. Esta degradação pode dever-se a diferenças 
na actividade enzimática das gelatinases MMP-2 e MMP-9.  
O beta-distroglicano pode estar relacionado com alterações na matriz extracelular que levam 
à plasticidade sináptica cerebral, que ajuda na recuperação funcional após AVC 
experimental. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Palavras-chave: AVC isquémico, enfarte, fototrombose, enriquecimento ambiental, matriz 
extracelular, metaloproteinases da matriz, beta-distroglicano 
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Chapter 1 
Introduction 
 
 
1.1 Ischemic stroke 
 
Worldwide, stroke is amongst the leading causes of death and serious disability (Go et al., 
2014), being the third cause in the Western world (Lo et al., 2003) (Figure 1). In Portugal, 
nearly 20.000 cases are reported each year (World Health Organization, 2014).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Estimated percentage of causes of death in Europe in 2004 (WHO). In 2004, 50% of deaths 
occurred due to cardiovascular diseases, among them Cerebrovascular Disease, such as Stroke (cause of 14% 
of all deaths). Stroke is the third cause of death in Europe, after Ischemic Heart Disease (24%) and Cancer 
(19%). Data analyzed from World Health Organization, 2004. 
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During stroke, there is a disruption in the blood supply to the brain leading to rapid loss of 
brain function (Chaturvedi and Kaczmarek, 2013; Lo et al., 2003).  
Strokes are classified as ischemic or hemorrhagic (Figure 2). Ischemic strokes are caused by 
obstruction of the blood supply, while hemorrhagic strokes results from rupture of a blood 
vessel. About 85–90% of the strokes are ischemic (Chaturvedi and Kaczmarek, 2013; Sicard 
and Fisher, 2009) and the treatment is still unsatisfying. Until today, the only treatment 
recommended for acute ischemic stroke is the recombinant tissue activator of plasminogen 
(rtPA), which aims to breakdown the blood clots. Nevertheless, only a few percentages of 
patients are eligible for rtPA administration (Chaturvedi and Kaczmarek, 2013; Kurzepa et 
al., 2014). 
 
 
 
 
 
Figure 2. Illustration of stroke pathology. Left: Representation of an ischemic stroke caused by a blood clot 
obstruction. Right: Representation of a hemorrhagic stroke caused by a rupture of a blood vessel. 
(Adapted from http://www.strokecenter.org/patients/about-stroke/ischemic-stroke/ and 
http://www.compelvisuals.com/compel_blog/basic-anatomy-of-the-brain-injuries-and-pathologies-an-illustrated-
review/). 
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Many factors can increase the risk of stroke. Elevated arterial blood pressure is a notable risk 
factor that normally is related to obesity (Zhao et al., 2006). Angiotensin-converting enzyme 
(ACE) inhibitors and diuretics lower the risk of stroke, in addition to other antihypertensive 
therapies (Lo et al., 2003). Another important risk is atherosclerosis. Treatment with statins 
reduces stroke risk (Lo et al., 2003). Genetic background is also acknowledged as an 
important stroke risk factor, wherein several genes can interact with the environment and 
affecting the risk of an individual. For instance, polymorphisms in genes such as ACE, 
endothelial nitric oxide synthase (eNOS), Apolipoprotein E (APOE) and beta-fibrinogen 
(FGB) apparently increase the risk of stroke (Lo et al., 2003). 
Brain ischemia is the condition or state wherein the brain is subjected to a lack of nutrients 
and to hypoxia or low oxygen because of an obstruction of the arterial blood supply or 
inadequate blood flow; and it can be divided into two classifications:  
• Global ischemia: the blood flow to the entire brain is transiently blocked, 
leading to a selective neuronal death and arises commonly as a 
consequence of cardiac arrest, open-heart surgery or carbon monoxide 
poisoning (Mohr et al., 2011) 
• Focal ischemia: also known as cerebral infarction, in which a specific area of 
the brain tissue undergoes injury; most strokes are caused by clots that form 
at the site of occlusion in a cerebral artery or move there from the heart (Mohr 
et al., 2011).  
In focal ischemia, the victims may die or become severely and permanently disabled, leading 
to paralysis, abnormalities in motor strength, coordination, sensory function and neurologic 
deficits including impaired cognition, visual disturbance and loss of sensation (Mohr et al., 
2011). The ischemic tissue includes the infarct or the core of the stroke, which contains cells 
that receive essentially no blood and rapidly die, and the penumbra or surrounding region, 
which contains cells that receive some blood from other arteries and may be salvaged 
(Figure 3). Cells in the infarct die from several causes and probably cannot be salvaged by 
any treatment short of immediate clot removal (Mohr et al., 2011) and also neurological 
functions related to this area is lost (Wieloch and Nikolich, 2006). During the next months 
following a stroke certain neurological functions are recovered specially during the first 30 
days but also for the next 6 months (Duncan et al., 2000). This functional recovery depends 
on the degree of tissue loss and engagement of neuronal networks that are involved in the 
lost brain functions (Wieloch and Nikolich, 2006).        
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1.2 Recovery after brain injury 
 
After injury in the cerebral cortex, as often occurs in stroke or traumatic brain injury (TBI), the 
sensorimotor area located in forebrain may be affected, resulting in deficits in motor function 
in the contralateral musculature. However, spontaneous functional recovery occurs in the 
weeks to months following injury (Nudo, 2013). It has been shown many examples of cortical 
plasticity and one of the most effective modulators of cortical structure and function is 
behavioral practice (Karni et al., 1998; Kleim et al., 1998; Nudo and Milliken, 1996; Nudo, 
2013). 
To help understand plasticity in adult brains, developmental neuroscience can be of help. 
During brain development, guidance clues for axonal sprouting are activity-dependent. In a 
later phase, cortical activity guides axonal sprouting within the cerebral cortex, leading to a 
connectivity patterns (Nudo, 2013). 
If there is a brain injury, an environment for axonal sprouting can be re-initiated, although it 
Figure 3. Affected areas on focal ischemic stroke. The infarct (core of the stroke) is the most affected area and 
receives essentially no blood supply, leading to neuronal death. The surrounding area, called penumbra, receives 
some blood flow, being less affected. 
(Adapted from http://www.clipartbest.com/clipart-di8xnor5T). 
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was once thought that it was non-existent in adult animals (Carmichael and Chesselet, 
2002).  
Anatomical alterations occur in adult animals as a consequence of behavioral training. 
Dendritic and synaptic morphology of motor cortex neurons are altered by specific motor 
learning tasks (Kleim et al., 2002). For instance, after 1 hour of limb task performance, 
dendritic spine formation occurs on pyramidal neurons (primary excitatory neurons) in the 
motor cortex contralateral to the limb (Nudo, 2013). Structural changes are highly specific to 
the neurons relevant for the trained task (Wang et al., 2011).  
The adult CNS holds an impressive capacity to recover and adapt following injury, such as 
spinal cord injury, TBI and stroke, called spontaneous functional recovery (Nudo, 2013). 
Much of the recovery that occurs after injury may be due to behavioral compensation. For 
instance, in a rat model of TBI, injured in the primary motor cortex, the forelimb area was 
affected. In the absence of rehabilitative training, leading to spontaneous recovery, 
behavioral performance on a pellet-reaching task improved over time, but at 5 weeks post-
injury, rats still have significant motor deficits (Nishibe et al., 2010). 
For development of recovery there is a process of both reinstatement and relearning of lost 
functions. Hence, it is thought that the neural plasticity that support learning in the intact 
cortex also mediate motor relearning and adaptation in the injured brain (Nudo, 2013).  
Data also has been shown that contiguous intact regions of the injured cortex might be 
involved in recovery after injury. For instance, motor cortex infarcts resulted in the 
somatosensory area to emerge in the undamaged motor cortex near the lesion, adding 
believability to the notion that uninjured regions help in this recovery (Nudo, 2013). 
Studies in human surviving stroke patients suggest that the peri-infarct cortex, still intact, 
may play a role in neurological recovery (Jaillard et al., 2005; Teasell et al., 2005). Fourteen 
to sixty days after stroke, synaptophysin staining is elevated, showing increased 
synaptogenesis. Local sprouting occurs in the peri-infarct area (Carmichael, 2006). New 
capillaries are also formed in the ischemic border (Wei et al., 2001). And after several weeks 
of rehabilitation, motor representations in the injured hemisphere are enlarged relative to the 
initial post-injury map (Carey et al., 2002). 
Some data show that there is dendritic damage in the ischemic core after photothrombotic 
stroke model, but this damage was limited to 300 µm around the ischemic border. Beyond 
this area, dendrites were intact. Hence, at least in this model of experimental stroke, a 
substantial substrate for structural and functional plasticity exists in the peri-infarct cortex 
(Nudo, 2013). In the same model, there is also an evidence of functional reorganization such 
as axonal sprouting, suggesting functional plasticity in this area (Clarkson et al., 2013).  
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In addition to the peri-infarct cortex, there is functional recovery in remote regions after focal 
injury. Injury of the motor cortex results in a disruption of sensorimotor networks, leading to a 
loss of fine motor control. It is possible to observe upregulation of a glutamate receptor 
(NMDA - N-methyl-D-aspartate receptor), in an excitatory level, and downregulation of 
GABAA receptors, inhibitory level, either in the ipsilesional and contralesional hemisphere 
(Redecker et al., 2000).  
Since the development of compensatory behaviors and commitment of undamaged primary 
motor cortex are thought to contribute to functional recovery, it can be that intact motor areas 
outside of primary motor cortex may also contribute to recover. Hence, after an injury in the 
primary motor cortex, the remaining intact motor areas provide some role in functional 
recovery, for instance via intracortical connectivity with other cortical regions and/or their 
direct corticospinal projection pathways (Nudo, 2013). 
Some studies show that somatosensory area near the primary motor cortex injured is also 
affected. Basically, the motor cortex cannot be considered solely as a motor structure. There 
are deficits resulting from sensorimotor disconnection. After primary motor cortex injury, 
there is a reduction of somatosensory input to motor areas, interfering with motor behavior 
(Nudo, 2013).  
Plasticity during recovery after brain injury is not only evident in the injured area, but also its 
surrounding areas are involved in this process, such as peri-infarct, somatosensory cortex 
(SS) and also the contralateral hemisphere. 
 
1.3 Recovery after stroke 
 
Stroke causes significant tissue damage, disruption of internal intricate circuits of the brain 
and its external neuronal connections that are involved in cognitive, sensory and motor 
functions (Nygren and Wieloch, 2005; Wieloch and Nikolich, 2006). During and immediately 
after stroke, neurological functions associated to the infarcted area are lost. During the 
subsequent months certain neurological functions recover but most patients have several 
disabilities. Recovery is most prominent during the first 30 days but continues for at least 6 
months and is dependent on the degree of tissue loss (Wieloch and Nikolich, 2006).  
Recovery of function involves three distinct phases: first, reversal of diaschisis and activation 
of cell repair, second, functional cell plasticity, that means changing the properties of existing 
neuronal pathways, and third, neuroanatomical plasticity leading to the formation of new 
connections. This sequence of events of brain plasticity is considered to be the basis for 
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spontaneous functional recovery after stroke (Wieloch and Nikolich, 2006).  
By this mechanism, stroke reorganizes cognitive maps in cortex in patterns that correlate 
with functional recovery (Carmichael, 2006). First, there is an induction of a bilateral cortical 
activation to sensory or motor stimulation of the affected limb. Later on during recovery, this 
bilateral pattern becomes more restricted, to a reorganized and expanded sensorimotor 
activation in the ipsilateral cortex of the stroke and an increase in activity in the connected 
regions of another motor and premotor areas of the contralateral side (Calautti et al., 2001; 
Carmichael, 2006; Tombari et al., 2004).  
It has been shown that this neurological functional recovery after stroke can be enhanced by 
external interventions, such as physical training in stroke patients. 
The American Heart Association/American Stroke Association states that physical training is 
“a subset of physical activity that is planned, structured and repetitive and has as a final 
objective the improvement or maintenance of physical fitness”, showing evidences that this 
training after stroke leads to a improvement of the cardiovascular fitness, walking ability and 
upper-extremity muscle strength (Billinger et al., 2014). The view of the world stroke 
researchers/professionals about physical training commencing early after stroke is 
consensual; however how early remains controversial (Billinger et al., 2014; Brethour et al., 
2012). Recent clinical trials have tested the beginning of the physical training within 24 to 72 
hours of stroke onset, yet with inconclusive results (Billinger et al., 2014).  
The exercises included in the physical training for stroke survivors are aerobic – including 
large-muscle activities, muscular strength, flexibility by stretching and neuromuscular 
exercises – such as balance activities (Billinger et al., 2014). 
In the animal settings, physical training can be accomplished by enriched environment (EE).  
 
1.3.1 Enriched environment 
 
Enriched environment refers to housing conditions, either home cages or exploratory 
chambers, that facilitate enhanced sensory, cognitive and motor stimulation relative to 
standard housing conditions, having larger cages with toys and tools (as tunnels, nesting 
material and food location changed often) or by training them 2-5 days after stroke (Figure 
4). Enrichment can also include increased social stimulation through housing the animals 
with several other individuals together (Nithianantharajah and Hannan, 2006; van Praag et 
al., 2000; Wieloch and Nikolich, 2006).  
The standard condition (STD) of an EE is “a combination of complex inanimate and social 
stimulation” which means that no single variable can account for the consequences of 
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enrichment (van Praag et al., 2000). For example: alone neither an EE with active 
participation nor EE with social interaction can lead to the effects of EEs (Rosenzweig et al., 
1978).  
Housing injured animals in an EE, 2-5 days after stroke, is an efficient way to stimulate 
functional recovery (Johansson, 2004). The effect of EE is not due to a decrease in infarct 
volume, since the size of the infarct area is the same in animals housed in different 
conditions (Johansson, 2004; Nygren and Wieloch, 2005). The effect of EE on functional 
recovery declines with time, and is not effective if started 30 days after stroke (Dahlqvist et 
al., 2003). Also, if initiated earlier than 2 days post-stroke it might be detrimental (Dahlqvist et 
al., 2003). 
Enriched environment induces biological effects in the brain that could account for the 
positive effect in recovery (Wieloch and Nikolich, 2006) and  activates brain plasticity 
mechanisms such as increased spine density, dendritic arborization, cell genesis, 
gliogenesis and angiogenesis (Johansson, 2004; Nithianantharajah and Hannan, 2006; 
Nygren and Wieloch, 2005; Wieloch and Nikolich, 2006). In addition, there are changes on 
the contralateral pyramidal neurons, showing that the contralateral hemisphere is involved in 
the recovery process (Johansson, 2004). Animals housed under EE showed enhanced 
astrocytogenesis in the ipsilateral peri-infarct area (Wieloch and Nikolich, 2006) and an 
increase in the number of neuronal stem cells and precursor cells in the subventricular zone 
and striatum but not the number of mature neurons (Komitova et al., 2005; Matsumori et al., 
2006). However, some data suggest that the recovery-enhancing effect on sensorimotor 
function by an EE is not due to generation of new neurons to the infarct or remote cortical 
areas (Wieloch and Nikolich, 2006). 
The extracellular matrix (ECM) is important in the regulation of brain plasticity (Frischknecht 
and Gundelfinger, 2012) but is also a potential hampering factor for recovery after stroke (Lo 
et al., 2003; Rosell and Lo, 2008; Soleman et al., 2013). 
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Figure 4. Housing conditions in different experimental groups and the effects of enhanced sensory, 
cognitive and motor stimulation in the brain. (a) A standard cage. (b) Cage for enriched environment with 
social interaction, stimulation of exploratory behavior with toys and tunnels. Enhanced sensory stimulation 
activates somatosensory (red) and visual (orange) cortices. Enhanced cognitive stimulation – as spatial maps – 
activates the hippocampus (blue). Enhanced motor activity – wheels and ladders – stimulates areas such as the 
motor cortex and cerebellum (green).  (Adapted from van Praag et al., 2000 and Nithianantharajah and Hannan, 
2006). 
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1.3.2 Role of the extracellular matrix in stroke  
 
The extracellular matrix (ECM) provides a microenvironment that regulates neural cell 
activity. It occupies the space between neurons and glial cells and restricts major 
reorganization of processes and axonal outgrowth, through the appearance of cartilage-like 
structures called perineuronal nets (PNNs) (Soleman et al., 2013; Wang and Fawcett, 2012).  
Perineuronal nets are a highly condensed form of the ECM of the central nervous system 
(CNS) distributed extensively in the brain and spinal cord (Hobohm et al., 2005; Karetko-
Sysa et al., 2011; Wang and Fawcett, 2012). PNNs surround cell bodies, proximal dendrites 
and initial axonal segments of some populations of neurons (Celio et al., 1998; Karetko-Sysa 
et al., 2011; Soleman et al., 2013; Wang and Fawcett, 2012), that are often parvalbumin-
expressing GABAergic (PV/GABA) interneurons (Härtig et al., 1994; Karetko-Sysa et al., 
2011).  
The accumulation of chondroitin sulfate proteoglycans (CSPGs) is the main feature of the 
PNNs (Hobohm et al., 2005; Karetko-Sysa et al., 2011). CSPGs comprise mainly aggrecan, 
brevican, neurocan and versican but they also contain hyaluronic acid, tenascins and link 
proteins (Bandtlow and Zimmermann, 2000; Galtrey and Fawcett, 2007; Karetko-Sysa et al., 
2011; Wang and Fawcett, 2012). These macromolecules form a dense, negatively charged 
net around the cell that is attached to the cellular surface, with some holes left at the sites of 
synaptic contacts on the neuronal membrane (Karetko-Sysa et al., 2011; Wang and Fawcett, 
2012). Hence, the PNNs appear to stabilize synapses but the inhibitory CSPGs may block 
the formation of new synaptic contacts and reduce the neuronal plasticity (Hobohm et al., 
2005; Soleman et al., 2013). 
ECM components may be affected by brain injury in different ways and their expression 
might be upregulated or reduced, which leads to function impairment; for instance in the 
regulation of synaptic plasticity (Hobohm et al., 2005).  
The number of PNNs is reduced after stroke induced by MCAO (Hobohm et al., 2005) and 
PT (Karetko-Sysa et al., 2011; Madinier et al., 2014). Earlier this year, Madinier et al. showed 
that this reduction is beneficial for recovery after stroke (Madinier et al., 2014).  
Stroke is followed typically by the development of glial scars, forming barriers that may 
protect the surrounding tissue but may also hamper reorganization and functional recovery 
and the deposition of CSPGs contributes to this hampering (Hobohm et al., 2005). 
Some CSPGs are highly expressed in the glial scar. In addition to upregulation of different 
matrix components in the glial scar, matrix remodeling after stroke is characterized by 
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increased expression of metalloproteinases and their tissue inhibitors, both involved in the 
proteolytic cleavage of ECM constituents (Hobohm et al., 2005; Planas et al., 2001). 
 
1.3.2.1 Matrix metalloproteinases 
Matrix metalloproteinases (MMPs) comprise a family of zinc endopeptidases associated with 
extracellular matrix remodeling involved in multifactorial actions in CNS physiology and 
pathology (Chaturvedi and Kaczmarek, 2013; Lee et al., 2004; Rosell and Lo, 2008; Zhao et 
al., 2006). They are secreted in a latent (inactive) form designated a pro-MMP or zymogens 
that require an activation and then they are able to cleave ECM components (Bode and 
Maskos, 2003; Planas et al., 2001; Snoek-van Beurden and Von den Hoff, 2005).  
In general, MMPs have common structural elements: 
• the signal peptide 
• propeptide (blocking of active centre in proenzymes) 
• catalytic domain with the zinc-containing active center 
• hinge region  
• hemopexin-like domain (binds to the inhibitors) (Kurzepa et al., 2014).  
By far, the most important common feature of those listed above is the Zn2+ in the active 
center, necessary for catalysis (Kurzepa et al., 2014).  
To this date, more than 20 MMPs have been identified and they are categorized based on 
the variations in the amino acid structure and affinity to substrates into the following groups 
(Kurzepa et al., 2014; Snoek-van Beurden and Von den Hoff, 2005): 
1. collagenases (MMP-1, MMP-8, MMP-13) 
2. gelatinases (MMP-2, MMP-9) 
3. stromelysins (MMP-3, MMP-10, MMP-11) 
4. matrilysins (MMP-7, MMP-26) 
5. membrane-type matrix metalloproteinases – MT-MMP (MMP-14, MMP-15, MMP-16, 
MMP-17, MMP-24, MMP-25) 
6. others (MMP-12, MMP-19, MMP-20, MMP-21, MMP-23, MMP-27, MMP-28) 
 
The MMPs activity is regulated at the level of gene transcription and the synthesis of pro-
MMPs (Snoek-van Beurden and Von den Hoff, 2005). In the propeptide domain of the 
MMPs, a cysteine residue (Cys73) is present, which functions as a stabilizer of the inactive 
proenzyme (Springman et al., 1990; Van Wart and Birkedal-Hansen, 1990). As referred 
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above, there is an active Zn2+ site in the catalytic domain, which forms a bond with Cys73. 
When this Cys73-Zn2+ is intact, the MMP is inactive. After the disruption of this bond, the 
MMP will be in the active form (Snoek-van Beurden and Von den Hoff, 2005; Springman et 
al., 1990; Van Wart and Birkedal-Hansen, 1990). In this dissociation, a water molecule binds 
to the Zn2+ ion replacing the cysteine residue. The noncatalytic zinc is switched to a catalytic 
one, which results in an intermediate active enzyme (Springman et al., 1990). Then, the pro-
domain of the MMP is removed by autolytic cleavage or by other proteases resulting in a fully 
active enzyme (Snoek-van Beurden and Von den Hoff, 2005; Springman et al., 1990; Van 
Wart and Birkedal-Hansen, 1990) (Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. The activation of pro-MMPs. The activation of latent MMPs involves a disruption of the Cys73-Zn2+ 
bond that results in an intermediate active form (from Snoek-van Beurden and Von den Hoff, 2005). 
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Besides, this activity is also regulated by several inhibitors, mainly by the tissue inhibitors of 
metalloproteinases (TIMPs) (Kurzepa et al., 2014; Planas et al., 2001; Snoek-van Beurden 
and Von den Hoff, 2005). TIMPs can bind to the active side of MMPs and block the substrate 
availability (Kurzepa et al., 2014). There are four forms of TIMPs (1 to 4) (Kurzepa et al., 
2014; Snoek-van Beurden and Von den Hoff, 2005). These TIMPs do not seem to 
differentiate between the various MMPs (Snoek-van Beurden and Von den Hoff, 2005). 
Current data suggest that MMPs have a deleterious role in acute stroke by degrading 
neurovascular matrix contributing to infarct extension and blood brain barrier (BBB) 
breakdown (Chaturvedi and Kaczmarek, 2013; Clark et al., 1997; Rosell and Lo, 2008). This 
role of MMPs can trigger brain cell death (Zhao et al., 2006). Hence, there is an effort in 
research to develop MMP inhibitors for acute stroke therapy (Chaturvedi and Kaczmarek, 
2013; Zhao et al., 2006).  
On the other hand at delayed stages after stroke, MMPs may have a different role. Since 
MMPs modulate brain matrix, they may mediate beneficial dendritic plasticity and ECM 
remodeling during stroke recovery (Zhao et al., 2006) (Figure 6). By degrading inhibitory 
matrix or glial scars, MMPs may allow axonal extension and recovery (Larsen et al., 2003). 
Basically, MMPs can have a role for neurovascular remodeling, affecting positively 
neuroplasticity, vascular recovery that may contribute to functional stroke recovery. Hence, 
MMPs comprise key molecules for promoting the remodeling of ischemic brain via 
angiogenesis, vasculogenesis or neurogenesis (Rosell and Lo, 2008).  
In particular, the gelatinases (MMP-2 and MMP-9) have been implicated specially in cerebral 
ischemia (Lo et al., 2002). Some data show that MMP-9 signals emerged in neurons and 
astrocytes of the peri-infarct cortex at 7-14 days after experimental stroke in rats. These 
studies suggest that the potentially beneficial actions of MMPs in this area may be mediated 
through delayed neurovascular remodeling and not through direct neuroprotection (Zhao et 
al., 2006). In the experimental settings, when they treated rats with two different MMP 
inhibitors 7 days after stroke, not only the infarction volumes at 14 days were worsened but 
also behavioral recovery was significantly blocked (Zhao et al., 2006). Regarding the other 
gelatinase, there is some evidence that MMP-2 plays an important role in the later stage of 
ischemia as well, during the formation of the glial scar within the damaged area (Kurzepa et 
al., 2014). Other studies with these gelatinases showed that MMP-2 and MMP-9 promote 
axonal outgrowth in injured peripheral nerve and were more expressed during maturation of 
the scar tissue of the injured adult spinal cord (Copin and Gasche, 2007). 
For some time, there were no data indicating a synaptic target for enzymatic activity of MMP-
9 even though this enzyme is implicated in neuronal/synaptic plasticity. However, one study 
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has showed that MMP-9 digests the 43 kDa β-dystroglycan (β-DG) to release a 30 kDa 
product, suggesting that this protein is targeted in response to enhanced neuronal activity 
(Michaluk et al., 2007).  
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Figure 6. MMP-9 is locally released at the dendritic spines in a non-active form. The propeptide that it is 
blocking the enzymatic active site is cleaved off by a cascade of extracellular proteases. Once activated, 
MMP-9 cleaves ECM proteins, such as dystroglycan. The cleavage products act on integrin receptors to 
transduce the signals provoking actin cytoskeleton modifications underlying the growth of spines. (Adapted 
from Dziembowska et al., 2012 and Michaluk and Kaczmarek, 2007). 
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1.3.3 Beta-dystroglycan 
 
Dystroglycan (DG) is a cytoskeleton-linked extracellular matrix receptor (Holt et al., 2000). It 
is formed by two sub-units, α and β, produced by proteolytic cleavage of a precursor, 
meaning that they are encoded by a single mRNA (Holt et al., 2000; Yamada et al., 2001; 
Zaccaria et al., 2001). This 160 kDa precursor propeptide is processed into α-DG form (120 
kDa) and β-DG (43 kDa) (Holt et al., 2000). 
α-DG is a highly glycosylated peripheral membrane protein. It binds to the extracellular 
matrix molecules laminin, agrin and perlecan with high affinity and in a calcium-dependent 
manner, and to the extracellular domain of β-DG (Zaccaria et al., 2001). β-DG spans the 
membrane, interacting intracellularly with the C-terminal cysteine-rich region of dystrophin or 
its homologue utrophin, or one of their truncated isoforms (Jung et al., 1995; Zaccaria et al., 
2001) (Figure 7). 
DG is expressed in a wide variety of tissues, including neural tissue. In the nervous system, 
given the presence of dystrophin, utrophin and their truncated forms, DG may participate in 
the formation of the dystrophin-associated glycoprotein complex (DGCs), which have an 
important functional role similar to that in the sarcolemma (Zaccaria et al., 2001). Even 
though there is not that much data showing evidence of DG presence in the brain, it has 
been shown that DG immunoreactivity for both subunits was widespread in the cerebral 
cortex, also there was β-DG-immunopositive hippocampal blood vessels; and α-DG present 
in postsynaptic specialization in the cortex (Zaccaria et al., 2001). 
As referred above, there are some studies suggesting that β-DG can be degraded by MMP-
9. First of all, a study showed that unidentified MMPs digest β-DG to reveal the 30 kDa 
product in the peripheral tissues (Yamada et al., 2001). Second, another study demonstrated 
that the appearance of the 30 kDa β-DG degradation product in the hippocampus coincides 
with increased levels of MMP-9 (Kaczmarek and Lapinska-dzwonek, 2002). Third, it was 
reported that β-DG expressed at the astrocyte endfeet can be specifically cleaved by 
macrophage-derived gelatinases (MMP-2 and MMP-9) in experimental autoimmune 
encephalomyelitis (Agrawal et al., 2006). Finally, Michaluk et al. provided evidence that β-DG 
is a target of neuronal MMP-9 in the brain in vivo as well as in neuronal cultures in vitro. This 
evidence was supported by the fact that MMP-9 was able to produce limited proteolytic 
cleavage of β-DG in brain neurons; this proteolysis occurred in response to synaptic 
activation and it was blocked by TIMP-1, a metalloproteinase inhibitor; the β-DG proteolysis 
into the 30 kDa form was absent in the MMP-9 knock-out mice; at last, the β-DG cleavage 
 35 
correlates in time with increased MMP-9 activity and β-DG and MMP-9 co-localize in 
postsynaptic elements in the hippocampus (Michaluk et al., 2007).  
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Figure 7. Distribution of dystroglycan complex in the brain. According with data presented previously, 
there are evidences that dystroglycan is widely spread in the brain. Lower image: It is connected to the 
endothelial cells in the brain vessels and on the astrocyte endfeet. Now, more recent data showed that beta-
dystroglycan is also located in the synapses. Upper image: Dystroglycan complex is composed by two 
subunits: alfa and beta (α and β). α-DG binds to the extracellular matrix molecules such as laminin and to the 
extracellular domain of β-DG. β-DG is a transmembranal protein that binds to utrophin/dystrophin and it is 
connected that way to actin cytoskeleton protein. It is this unit that interacts with the ECM. (Adapted from 
Ross, 2002). 
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1.4 Experimental background 
 
The next pages serve the purpose of explaining some of the techniques that can be 
employed in experimental stroke studies. 
 
1.4.1 Experimental models for ischemic stroke 
To study the underlying molecular and biophysical mechanisms in ischemic stroke, there are 
several in vitro and in vivo models available. 
 
1.4.1.1 In vitro models: 
Oxygen glucose deprivation (OGD) of cell cultures or brain slices is the most established and 
widely used in vitro model for ischemia (Chaturvedi and Kaczmarek, 2013; Mohr et al., 
2011). The cells can be incubated in deoxygenated, glucose-free medium, lacking the supply 
of oxygen and nutrients (Chaturvedi and Kaczmarek, 2013).  
 
1.4.1.2 In vivo models: 
In vivo models have greater physiologic validity than in vitro models (Mohr et al., 2011). 
Models of cerebral ischemia can be separated into focal and global ischemia models 
(Bacigaluppi et al., 2010). 
 
1.4.1.2.1 Models of global ischemia 
These models are applied in rodents, pigs and dogs (Bacigaluppi et al., 2010)  and can be 
induced by means of different approaches: 
• Four vessel occlusion method (4VO): reversible common carotid artery (CCA) 
occlusion, which, combined with permanent interruption of the vertebral arteries via 
electro cauterization, results in a bilateral forebrain and brainstem ischemia (Pulsinelli 
and Brierley, 1979). 
• Two vessel occlusion method (2VO): occlusion of the two common carotid arteries 
together with induction of hypotension for a limited time period This model was 
developed in our laboratory (Smith et al., 1984).  
• Cardiac arrest and resuscitation: induction of ventricular fibrillation followed shortly 
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thereafter by defibrillation combined with chest compression and administration of 
epinephrine (Bacigaluppi et al., 2010). 
1.4.1.2.2 Models of focal ischemia 
Focal ischemia is the animal model that most closely mimic the changes that occur in 
cerebral infarction or stroke in humans (Braeuninger and Kleinschnitz, 2009; Sicard and 
Fisher, 2009) and it is typically performed in rodents such as rats or mice (Mohr et al., 2011).  
• Occlusion of middle cerebral artery (MCAO) it is the most frequently used procedure 
and is induced through the insertion of a suture filament into the internal carotid 
artery, occluding the MCA at its origin. MCAO can be transient or permanent MCAO. 
In the transient MCAO (tMCAO), the suture filament is left transiently (times ranges 
between 30-120 min) before the suture is removed to enable the tissue reperfusion. 
In case of permanent MCAO (pMCAO) the suture is left in place and no reperfusion 
will occur (Bacigaluppi et al., 2010). After this procedure, the core is defined as the 
brain area which blood flow is reduced to less than 10%, affecting the lateral portion 
of the caudate putamen and the parietal cortex; by the other hand, the penumbra is 
the area which blood flow is reduced to less than 40%, affecting the entorhinal cortex 
(neocortex) and medial caudate-putamen (Mohr et al., 2011). 
• Endothelin-1 model: this model achieves reversible occlusion of the middle cerebral 
artery (MCA) through direct or nearby application of the potent vasoconstrictor 
endothelin-1 (ET-1) (Canazza et al., 2014; Sharkey et al., 1993; Sicard and Fisher, 
2009). When ET-1 is applied to the MCA there is a significant decrease of cerebral 
blood flow in its territory, resulting in an ischemic lesion pattern similar to that of direct 
surgical MCAO (Macrae et al., 1993; Sicard and Fisher, 2009). After approximately 
20 minutes of severe cerebral blood flow reduction, there is a slow and progressive 
return of the blood flow to normal with the rate being dose-dependent (Macrae et al., 
1993; Sicard and Fisher, 2009). In this model, there is an absence of lesions at 
injection site (Canazza et al., 2014). 
• Thromboembolic model: it can be induced in animals through an injection of synthetic 
macro/microspheres (Bacigaluppi et al., 2010) or of a blood clot into the internal 
carotid artery (Bacigaluppi et al., 2010; Canazza et al., 2014; Sicard and Fisher, 
2009). This model is of great interest to researchers because it is the closest in 
resemblance to human ischemic stroke and it can be used to evaluate thrombolytic 
therapies (Bacigaluppi et al., 2010; Braeuninger and Kleinschnitz, 2009; Canazza et 
al., 2014; Sicard and Fisher, 2009).  
• Photothrombosis model (PT): In 1985, Watson et al. introduced PT as a technique to 
induce focal cerebral infarction in the cortical vasculature of rats (Watson et al., 
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1985). In this model, a cortical brain lesion is induced by systemic injection of a 
photosensitive dye, such as Rose Bengal, and subsequent trans-cranial irradiation of 
the brain by a light beam, leading to the coagulation of the irradiated tissue 
(Bacigaluppi et al., 2010; Braeuninger and Kleinschnitz, 2009; Chaturvedi and 
Kaczmarek, 2013; Sicard and Fisher, 2009; Watson et al., 1985). Oxidative damage 
to the vascular endothelium caused by the altered dye leads to the platelet 
aggregation in that brain region and subsequent thrombotic vessel occlusion 
(Braeuninger and Kleinschnitz, 2009; Chaturvedi and Kaczmarek, 2013; Sicard and 
Fisher, 2009). This model does not require craniotomy because the light can 
penetrates the skull, so it can be less invasive (Braeuninger and Kleinschnitz, 2009). 
The main advantage of this procedure is the high reproducibility of lesion size and 
location, so the region of ischemia can be predefined and circumscribed being 
possible to selectively induce infarcts in cortical areas representing specific functions 
(Bacigaluppi et al., 2010; Braeuninger and Kleinschnitz, 2009; Sicard and Fisher, 
2009). A disadvantage of this model is that vasogenic edema and blood-brain barrier 
breakdown occur within minutes which does not allow the formation of penumbra 
(Sicard and Fisher, 2009), creating a lesion with a small ischemic penumbra 
compared to other focal stroke models (Bacigaluppi et al., 2010).  
 
 
1.4.2 Behavioral tests 
 
Motor, sensory and cognitive deficits are common after stroke. Developing and using tests 
that have the ability to identify behavioral deficits is essential to measure the functional 
outcome in animal models and to give valuable insight of the biological changes in the brain 
following experimental stroke (Schaar et al., 2010). Since the stroke model employed in our 
experiments (PT) damages unilaterally the brain, the following behavioral tests can be 
considered relevant to assess the deficits. 
 
1.4.2.1 Paw placement test 
The paw placement (PP) test provides information on the tactile/proprioceptive response to 
limb stimulation (Madinier et al., 2014).  
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First described in 1995 by Garcia et al., the PP was part of the Neuroscore, an overall test 
done to evaluate neurological function and sensorimotor deficits after stroke (Garcia et al., 
1995).  
In this test, the animal is placed with the 4 paws in a platform top, hand-held and immobile, 
and the paws of the side to be tested along the edge. When the rat is moved over the edge, 
the paws loose the contact with the surface. Then the ability of the animal to replace the paw 
up back to the platform surface was assessed as described in 1992 by De Ryck et al. (De 
Ryck et al., 1992). For this assessment, it is also important to hold the head of the rat at 45º 
degrees angle avoiding the visual and whisker/snout stimulation (De Ryck et al., 1992; 
Madinier et al., 2014).  
 
1.4.2.2 Corner test 
The corner test is a sensorimotor functional assessment that has been shown to be reliable 
for identifying and quantifying sensorimotor and postural asymmetries; also to provide a 
simple way of detecting contralateral and ipsilateral turning biases (Schaar et al., 2010). In 
1982, when this test was first described, it has been shown to be relevant to investigate the 
unilateral nigrostriatal damage in the rat (Schallert et al., 1982) and later, it was used to focal 
cerebral ischemia in the mouse (Zhang et al., 2002).  
The apparatus consists of two boards placed closely together at a 30 degrees angle to form 
a narrow alley. An animal when placed facing the corner, both sides of the vibrissae are 
simultaneously stimulated which leads the animal to rear and turn 180 degrees. Intact 
animals will usually turn around to the right or left randomly while animals with unilateral 
brain damage will preferentially turn around in the ipsilateral direction, leading with the non-
impaired limb and displaying and asymmetry in corner turning (Chen et al., 2010; Hua et al., 
2002; Schaar et al., 2010; Zhang et al., 2002). 
Baseline or pre-training is recommended for the reduction of variability and identification of 
preferential side. In addition to identifying sensorimotor deficits, the corner test has been 
shown to be an objective assessment of long-term functional outcome (up to 90 days) after 
stroke in both the rat and the mouse (Schaar et al., 2010; Schallert, 2006).  
 
1.4.2.3 Corridor test 
The corridor test is a test of sensorimotor integration that depends on a rat’s ability to retrieve 
food from either side of its body (Dowd et al., 2005; Fitzsimmons et al., 2006).  
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It has been shown that rats with unilateral dopamine depletion and with unilateral lateral 
hypothalamic lesions neglect the pellets on the contralateral side of their bodies, and 
preferentially retrieve pellets from the ipsilateral side (Dowd et al., 2005; Fitzsimmons et al., 
2006; Marshall and Teitelbaum, 1974) 
In this test, restricted fed (hungry) rats are placed into a long, narrow corridor in which pots of 
sugar pellets are placed on the left and right sides, they are then free to retrieve pellets from 
either side of their bodies (Dowd et al., 2005; Fitzsimmons et al., 2006).  
Baseline performance is required for the same reasons of the corner test.  
 
 
1.4.3 Biomolecular techniques 
Quantitative analysis of molecular proteins, such as Western blot and zymography, define 
the amount of protein in a sample or how active that protein is. Since qualitative analyses just 
show the presence or absence of the protein of interest, it is important to perform additional 
analyses in a quantitative way. Qualitative and quantitative analyses are made in same way, 
but in quantitative analyses imaging techniques are then used to assess the quantification of 
either protein amounts or enzymatic activity. 
Western blot analysis is a powerful tool for protein detection where we can know the exact 
protein amount in the sample. Zymography is used for detection of enzymatic activity of 
matrix metalloproteinases. 
 
1.4.3.1 Western blotting 
The Western blot is an analytical technique used for specific protein detection in a sample of 
tissue extract.  
In this technique, the proteins are separated by gel electrophoresis. The proteins run through 
a polyacrylamide gel under denaturing sodium dodecyl sulfate (SDS) conditions and they are 
separated by the molecular weight. 
The proteins in the gel are transferred to a membrane of polyvinylidene fluoride (PVDF) by 
electric current, then they are incubated with specific antibodies for the target protein (Renart 
et al., 1979; Towbin et al., 1992).  
The blocking step is also very important. This step prevents the non-specific binding of the 
antibody to the membrane and other proteins. For that it can be used bovine serum albumin 
(BSA) or non-fat dry milk in a tris-buffered saline (TBS) with a detergent such as Tween 20. 
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This reduces extra bands in the final product of the Western blot (Renart et al., 1979; Towbin 
et al., 1992).  
After incubation with the specific primary antibody, there is the detection step. During the 
detection step, the membrane is “probed” for the protein of interest with a secondary 
antibody linked to a reporter enzyme, normally horseradish peroxidase. When this enzyme is 
exposed to an appropriate substrate (chemiluminescent agent), the substrate is cleaved and 
the reaction produces luminescence in proportion to the amount of protein. It is then exposed 
to the light then showing an image of the bands having the molecular size of the protein of 
interest. The bands are quantified by densitometry.  
 
1.4.3.2 Zymography 
A currently used technique to analyze the expression of MMPs is zymography. In this 
technique, it is possible to identify MMPs by the degradation of their preferential substrate 
and by their molecular weight. One can also determine whether the MMP is in an active or 
pro form (Snoek-van Beurden and Von den Hoff, 2005).  
In zymography, the proteins are separated by electrophoresis under SDS conditions, such as 
in Western blot. The separation occurs in a polyacrylamide gel containing a suitable 
substrate that is co-polymerized with the acrylamide (called zymogram) (Heussen and 
Dowdle, 1980). 
Since SDS causes reversible denaturation of MMPs, the gel must be rinsed, so that SDS is 
removed and the MMPs can renature and recover their enzymatic activity (Heussen and 
Dowdle, 1980; Snoek-van Beurden and Von den Hoff, 2005). Then, during the incubation of 
the gel in an activation buffer, the renatured MMPs in the gel will digest the substrate 
included in the gel (Snoek-van Beurden and Von den Hoff, 2005).  
Subsequently the gels are exposed and the void will appear as bands quantified by 
densitometry. 
Gelatin Zymography is the zymography used for detection of gelatinases, MMP-2 and MMP-
9 and it is based on some specific principals such as: during electrophoresis, the MMP 
substrate gelatin is integrated in the polyacrylamide gel; the separation of MMP-TIMP by 
SDS enables independent detection; both pro- and the active forms of MMPs can be 
distinguished by their molecular weight (Snoek-van Beurden and Von den Hoff, 2005). 
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Chapter 2 
Aims  
 
 
The study underlying this master thesis was conducted to investigate changes of some 
components of the ECM in the brain after experimental stroke, and how housing animals in 
an enriched environment after stroke affects these components. First of all, we were 
interested to know if EE affects the expression of β-DG after experimental stroke.  
Also, because there is evidence showing β-DG as a target of MMP-9, we decided to see how 
this matrix metalloproteinase is affected by stroke and consequently after recovery. Since 
MMP-9 is a gelatinase, we analyzed as well the activity of gelatinase MMP-2.  
In addition, we wanted to know how was the behavioral outcome after one week of recovery 
after experimental stroke when animals were either housed in an enriched or standard 
environment. 
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Chapter 3 
Methodology 
 
 
3.1 Animal studies 
 
This work was done with 31 animals, which were divided into two groups: Group A (n= 20) 
and Group B (n = 11). Group A was used to study infarct volume measurement, 
immunohistochemistry and immunofluorescence. Group B was used to study behavioral 
assessment and to perform Western blotting and zymography. The experiments were carried 
out on male Sprague Dawley rats (8 weeks, Charles River). 
 
3.2 Experimental design 
 
We performed two studies. Both studies had the same duration of recovery: 7 days after 
experimental stroke. The day when PT was performed was considered day 0. After 2 days, 
there was a selective sorting and randomization into either EE or STD cages during 5 days. 
At day 7, the rats were sacrificed.   
In the first study, group A of animals (n=20), served the purpose of assessing the infarct 
volume and in the same brains immunohistochemistry analyses were performed (Figure 8).  
 
 
 
 
 
 
 
 
 
 
 
Figure 8.  Study group A: n=20. Sham EE: n=5; Sham STD: n=5; EE: n=5; STD: n=5. These animals were used 
for infarct volume measurement, immunohistochemistry and immunofluorescence. 
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In the second study, group B of animals (n=11), the animals were used for behavioral 
assessment after experimental stroke, as well as Western blotting and zymographic analyses 
(Figure 9).  
 
 
     
 
Figure 9. Study group B: n=11. Sham n=4; EE n=4; STD n=3. These animals were used to perform behavioral 
assessment and techniques such as Western blotting and zymography. 
 
3.3 Permanent focal ischemia by PT 
 
Rats of both groups A and B were housed under reverse light conditions, with the testing 
performed during the dark period when the rats are active.  
The animals were anesthetized by isoflurane (approximately 2% in O2 under spontaneous 
ventilation) and placed into a stereotaxic frame with sensorimotor cortex coordinates. 
Corporal temperature was monitored during surgery using a rectal temperature probe and 
animals were kept at 36.8–37.6 ± 0.3 by means of a heating pad with feedback control 
(Supplementary Table 1). The skin above the skull was incised. Thereafter, the dye Rose 
Bengal (3.2 ml at 10 mg/ml) was injected in the tail vein. Two minutes after injection, the skull 
was illuminated with cold light (Schott, KL 1500 LCD) on an area of 8 to 4.5 mm for 20 min 
(from +4 to -4 mm antero-posterior and from 0.5 to 5 mm on the left from bregma) (Figure 
10). The tail and the scalp incisions were sutured and the rats transferred to their home cage 
with free access to food pellets and water. The functional deficit was assessed 2 days after 
the onset of the stroke using the paw placement test and then after one week. Control rats 
(sham), after the incision of the skull, were subjected to Rose Bengal injection without 
subsequent illumination (Group A = 5; Group B = 4). 
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3.4 Selective sorting, randomization and EE 
 
On day 2 after PT, a selective sorting was performed, where only rats with total paretic limbs 
were included in both studies (score in paw placement test = 0, see below). This was done in 
order to obtain groups with a similar functional deficit. After this selective sorting, animals 
were randomized and kept either in pairs in standard laboratory cages (STD) (Group A = 5, 
Group B= 3) or all together (Group A n=5, Group B n=4) in a EE cage with 8 rats (animals 
excluded from the study were used to fill up the cages) for 1 week as described in both 
Figures 8 and 9. No animal died during either surgeries or recovery.  
 
3.5 Behavioral tests 
 
3.5.1 Paw placement 
The paw placement (PP) test provides information on the tactile/proprioceptive response to 
limb stimulation. Animals (Group B) were placed with all 4 paws on the table top, and the 
paws to be tested along the edge. Each rat was moved over the edge with the paws to be 
tested in loose contact with the table surface. The ability of the animals to place the limb 
back onto the table surface when the rat was moved toward the edge was evaluated. 
Importantly, the head was held at 45º angle, so that visual and whisker/snout stimulation was 
prevented. The placement of each paw was recorded when the rat was moved towards the 
edge. Sensorimotor dysfunction was assessed by using a score of 1, 0.5 and 0: (1) – the 
paw is immediately placed on the table surface; (0.5) – the limb is extended, but some 
Figure 10. Location of bregma. The PT was perfomed from +4 to -4 mm antero-posterior and from 0.5 to 5 
mm on the left from bregma (from Paxinos and Watson, 2013: The Rat Brain in Stereotaxic Coordinates). 
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movements and attempts to place the paw on the surface of the table; (0) – the paw is totally 
immobilized, hanging down, with no movement. To obtain the assessment during recovery, 
each rat was tested at 2 and 7 days after PT stroke.  
 
3.5.2 Corner and corridor tests 
The corner and corridor tests were performed in the same platform. The corridor had a length 
of 150 cm, and the pots with 10 sugar pellets were placed 10 cm of distance between each 
other; one of the pot on the right side, 10 cm after the other on the left side. In the end of 
each side of the corridor, there was a corner forming ~45º degrees. The animals of group B 
performed 3 baselines before PT to assure they recognized the environment. The 
assessment of both tests was done 7 days after experimental stroke. Each head turn was 
counted as 1 point. After that, the percentage of the turning biases for each side for both, 
corridor and corner test were calculated.  
 
3.6 Tissue collection 
 
3.6.1 Group A 
At 7 days after PT, rats of group A were anesthetized with isoflurane and perfusion-fixed with 
4% paraformaldehyde (PFA) solution. Brain were collected and immersed in 4% PFA 
solution for 4 h, then transferred into 25% sucrose phosphate buffer solution (0.1 M 
NaH2PO4, 0.1 M Na2HPO4) and stored at 4ºC. Brains were then cut in 30 µm slices using a 
microtome and the slices were kept for infarct size measurement, immunohistochemistry and 
immunofluorescence. All the slices were stored in anti-freeze solution (30% ethylene glycol, 
30% glycerol, 0.01 M NaH2PO4, 0.03 M Na2HPO4) at -20ºC.  
 
3.6.2 Group B 
At 7 days after PT, rats of group B were deeply anesthetized with isoflurane and decapitated. 
Brains were removed, freed from meninges and immediately frozen in isopentane (-40ºC) 
and further cooled down to -70ºC on dry ice and -80ºC for storage. Tissue samples were 
collected from 2 to 3 mm thick sections (from the beginning of the infarct to posterior areas), 
of the SS (Figure 11) and further homogenized in cell lysis buffer (see Western blot and 
Real-time gel zymography section).  
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3.7 Infarct volume measurement 
 
For each animal of group A in EE and STD cages, the brain slices were immunostained with 
the monoclonal NeuN antibody (Neuronal Nuclei, Millipore, Hampshire, UK; dilution 1:1500). 
All slices were scanned, the non-lesioned area of the infarcted hemisphere and the non-
lesioned contralateral hemisphere were outlined and measured using ImageJ software 
(National Institute of Health, USA). The infarct volume (mm3) was then calculated by 
integration of the different areas (Swanson et al., 1990). 
 
3.8 Western blotting 
  
Whole cellular protein extractions from the dissected SS region were performed by 
mechanical homogenization and incubation in lysis buffer: 20 mM Tris (pH 7.5), 150 mM 
NaCl, 1mM EDTA, 1mM EGTA, 1% Triton-X100, 2.5 mM sodium pyrophosphate, 1mM β-
Figure 11. Brain areas. After PT, the motor cortex was injured (M). The somatosensory cortex (SS) was left 
intact and further homogenized. (Cg: cingulate cortex; cc: corpus callosum) (Adapted from Paxinos and 
Watson, 2013: The Rat Brain in Stereotaxic Coordinates). 
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glycerolphosphate, 1mM orthovanadate, 1mM PMSF, supplemented with a protease inhibitor 
cocktail (P2714, Sigma). Following 15 min incubation, samples were centrifuged at 14000 
rpm, for 20 min. Total protein concentration was determined by the Bradford assay, using 
bovin albumin (Sigma) as standard.  
Twenty micrograms of protein of brain samples of both ipsilateral and contralateral sides of 
the SS belonging to the rats of group B were separated on a 10% SDS polyacrylamide gel. 
Blocking was performed onto polyvinyldifluoride (PVDF) membranes using blocking buffer 
(20 mM Tris, 136 mM NaCl, pH 7.6, 0.1% Tween 20, 5% nonfat dry milk), and detected using 
a monoclonal antibody against Beta-dystroglycan (Abcam, England, UK; dilution 1:500). After 
incubation overnight at 4ºC, signals were obtained by the binding of a secondary anti-mouse-
HRP antibody (Sigma, Germany; dilution: 1:10000) and visualized by exposing the 
membrane under a CCD camera (LAS1000, Fujifilm, Japan) using a chemiluminiscence kit 
(Immobilon Western Chemiluminescent HRP Substrate, Millipore, Hampshire, UK). 
Membranes were stripped and reprobed for β-actin (Sigma, Germany; dilution: 1:75000). 
After densitometric analysis using the ImageJ software (National Institute of Health, USA), 
beta-dystroglycan expression was calculated as percentage of β-actin expression. 
 
3.9 Real-time gel zymography  
 
The extraction of MMPs from brain tissue followed the procedure by Szklarczyk (Szklarczyk 
et al., 2002) with some modifications. Tissue samples were weighed and then homogenized 
in a ice-cold buffer containing 10 mM CaCl2 and 0.25% Triton X-100 in water (20 µl of 
buffer/1 mg of wet tissue). The homogenates were centrifuged at 9100 rpm for 30 min at 
4°C. 
The entire supernatant containing soluble proteins (Triton X-100-soluble) was quantitatively 
recovered. Proteins from the supernatant were precipitated in 60% ethanol for 5 min at 4°C 
and then centrifuged at 14000 rpm for 5 min. The precipitate was solubilized in 100 µl of non-
reducing SDS-sample buffer for 15 min at 37°C. 
The pellet (Triton X-100-insoluble) was resuspended in a buffer containing 50 mM Tris, pH 
7.4, and 0.1 M CaCl2 in water, heated for 15 min at 60°C, and then centrifuged at 12500 rpm 
for 30 min at 4°C. This treatment results in releasing ECM-bound MMPs into the solution. 
The final supernatant was considered a Triton X-100-insoluble fraction. After centrifugation, 
the entire supernatant was quantitatively recovered. The proteins from the supernatant were 
precipitated and finally solubilized in 50 µl of sample buffer. 
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Protein concentration was measured by the Bradford method, using 20 µl of samples 
removed immediately before precipitation. Samples were stored at -80°C. 
The samples prepared from the Triton X-100 insoluble fraction were separated on 8% SDS-
PAGE gel co-polymerized with 0.2% FITC-labeled gelatin. FITC labeling of the gelatin 
(Sigma) followed the protocol of Hattori (Hattori et al., 2002). Gels were washed twice for 30 
min in 2.5% Triton X-100 to remove SDS and incubated for 2 d in 50 mM Tris, pH 7.4, 10 mM 
CaCl2, 1µM ZnCl2, 1% Triton X-100, and 0.02% sodium azide at 37°C. Gels were digitally 
photographed in UV light (ChemiDoc XRS+ System, Bio-Rad). Enzymatic activity is detected 
as dark bands against a bright fluorescent background and it was quantified by densitometry 
of gelatinolytic bands using the ImageJ software (National Institute of Health, USA). 
 
3.10 Immunohistochemistry 
 
Free-floating brain slices of group A were rinsed three times in PBS (phosphate buffer saline) 
and quenched in 3% H2O2 (Hydrogen Peroxide) and 10% MetOH (Methanol) for 12 minutes. 
After washing in PBS, the sections were blocked with blocking solution (5% normal donkey 
serum, Jackson ImmunoResearch, UK and 0.25% Triton X-100) in PBS) for 1 h at room 
temperature. The sections were incubated overnight at 4ºC with primary antibody (mouse 
monoclonal anti-beta-dystroglycan, Abcam, England, UK; dilution: 1:200) diluted in blocking 
solution. Following three rinses with 1% normal serum and 0.25% Triton X-100 in PBS, the 
sections were incubated with appropriate secondary biotinylated antibodies (donkey anti-
mouse-biotin; Sigma-Aldrich, USA; dilution 1:500) in blocking solution for 90 min at room 
temperature (RT). Visualization was achieved via the Vectorstain ABC kit (vector) using 3,3-
diaminobendizine-tetrahydroklorid (DabSafe, Saveen Werner, Sweden), 8% NiCl and 3% 
H2O2. Bright field pictures were acquired using an Olympus BX60 microscope (Solna, 
Sweden). 
 
3.11 Immunofluorescence 
 
Free-floating brain slices of group A were rinsed three times in PBS and blocked with 
blocking solution (5% normal donkey serum, Jackson ImmunoResearch, UK and 0.25% 
Triton X-100 in PBS) for 1 h at RT. The section were incubated overnight at 4ºC with primary 
antibody (mouse monoclonal anti-beta-dystroglycan, Abcam, England, UK; dilution: 1:200; 
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rabbit anti-PSD-95, Synaptic Systems, Germany; dilution 1:500; rabbit anti-SYP-Ab4, 
Thermo Fisher Scientific, USA; dilution 1:200) diluted in blocking solution. Following thee 
rinses with 2% normal serum and 0.25% Triton X-100 in PBS, the sections were incubated 
with appropriated secondary antibodies (donkey anti-mouse-biotin, Sigma-Aldrich, USA); 
dilution 1:500) conjugated with either fluorescent dyes Cy3/Cy5 (Jackson ImmunoResearch, 
UK) and Streptavidin Alexa Fluor 488 conjugate (Molecular Probes, Invitrogen, USA) at a 
dilution of 1:100 in blocking solution for 90 min at RT. Fluorescent dyes were imaged using a 
confocal laser-scanning microscope (Zeiss LSM 510, Jena, Germany). 
 
3.12 Statistical analysis 
 
All data are presented as mean ± SD (standard deviation), unless otherwise stated. 
Statistical analysis was performed with the two-tailed unpaired Student’s t-test for the infarct 
size comparison, Kruskal-Wallis for the behavioral tests, one-way ANOVA for the Western 
blot analyses and Real-time gel zymography. P<0.05 was considered statistically significant. 
Data handling and statistical processing were performed using Microsoft Excel and 
GraphPad Prism Software.  
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Chapter 4 
Results & Comments 
 
 
4.1 Enriched environment does not affect infarct size after PT 
 
We started with the analysis of the infarct volume size. Figures 12A and B show the location 
of the cortical infarct one week after PT as displayed in the NeuN stained coronal section of a 
rat brain. The lesion is localized approximately 8 mm caudally from the frontal cortex, 
affecting fore and hind paw motor areas of the motor cortex. The cingulate (cg) cortex was 
left intact such as large parts of the SS (Figure 11).  The lesion extended from the cortical 
surface down to the corpus callosum (cc), but did not transect the white matter.  
The lesion localization in the EE (Figure 12B) and STD (Figure 12C) groups was the same. 
The mean size of the infarct in the EE at 1 week after PT was 36±15 mm3, while in the STD 
housed animals the mean infarct volume was 33±13 mm3 (Figure 10D). 
 
Thus, EE does not affect the volume of the infarct. Animals housed either in EE or STD 
cages, at 2 days after PT and staying there 5 days, had the same infarct size.  
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Figure 12. Infarct volume measurement. Infarct volume was measured at 1 week after PT and estimated by 
integration of the lesioned area on brain slices taken the distance from bregma showed in the figures (A) and (B). 
NeuN staining staining was performed to distinguish between intact and death tissue. (A) Coronal brain slices of a 
representative brain infarct with the respective distances from bregma for the EE housed animals and (B) STD 
housed animals. (C) Infarct volume expressed in mm3. Values are presented as mean ± SD and tested with two-
tailed unpaired Student´s t-test (n=5 for each housing condition; EE: enriched environment; STD: standard 
environment). 
 
A B 
C 
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4.2 Enriched environment enhances sensorimotor function after 
lesions in the motor cortex 
 
4.2.1 Paw placement test 
 
Early this year, a study performed in the same lab where I have accomplished my thesis 
showed that the animals housed in EE after experimental stroke recovered the limb 
placement ability better than STD animals and this was assessed by the PP test (Madinier et 
al., 2014). In that study, a difference was found in behavioral recovery between the two 
different housing groups, EE and STD, in the PP test. 
As described in the methodology, in this test, visual and whisker/snout stimulation was 
prevented, so the behavioral response can be only be due to tactile/proprioceptive response 
to the limb stimulation. 
In both groups, EE and STD, the fore and hind paws on the side of the lesion were 
unaffected. Whereas the contralateral paws were both affected as it is shown in Figure 13.  
At 7 days of stroke recovery, the EE housed animals recovered quickly. They achieved 
scores close to the ones of the sham animals. There was no significant difference between 
the two groups (EE and sham), both fore (Figure 13A) and hind paws (Figure 13B) 
recovered. Even when both paws were analyzed together, there was no significant difference 
(Figure 13C). 
In contrast, the STD housed animals did not recover any function of both fore and hind paws 
7 days after stroke, receiving a score of 0 (Figure 13D). There was a significant difference in 
the score obtained by the STD animals, comparing to the sham animals, where both of their 
paws have a score of 1 (Figure 13F). 
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Figure 13. Paw placement test. Limb placing ability of rats subjected to PT under conditions that prevent 
visual and whisker/snout stimulation during testing. (A) The hind paw is hanging, totally paretic. This 
behavior is scored with 0. The forepaw, where the rat is grabbing the edge of the table but it is not able to 
put it up, it is scored with 0.5. (B) Both paws, hanged and paretic, are scored with 0. (C) The rat does not 
hang in any point the both paws, putting automatically the paw back to the edge of the table. This behavior 
is scored with 1. This is the normal score before PT for rats. (D) Fore paw placement, (E) hind paw 
placement and (F) both paws placement. The scores are the mean value of the score for the group with SD, 
tested with Kruskal-Wallis  (Group B: Sham n=4, EE n=4, STD=3; *: p<0.005) when Sham compared to 
STD; EE: enriched environment; STD: standard environment). 
 57 
4.3 The corner and corridor tests 
 
The lesion caused to the motor cortex impairs paw functions in the contralateral side of the 
lesion. As mentioned above, the corner and corridor tests are used to assess sensorimotor of 
postural asymmetries and turn biases. They have been used in unilateral lesions, for 
instance in experimental models of Parkinson’s disease, where the contralateral body side is 
affected.  
 
4.3.1 Corner test 
 
In this test, it was counted how many 180º degrees turns and which side has been chosen by 
the rat during 10 minutes of the test, after passing through all the corridor way. With the total 
of turns performed, it was calculated the percentage of turns done to each side.  
There was no difference either on turning to the right or turning to the left between sham 
animals and PT animals, or even between EE and STD housed animals (Figure 14). 
Hence, it looks like PT does not affect the turn biases at 7 days of recovery after stroke.  
 
 
 
  
Figure 14. Corner test. Turn of 180º biases of rats subjected to PT during 10 min testing. (A) Percentage of body 
turns to the left and (B) to the right. (C) Compares both sides percentage. Each body 180º degrees turn of the rat 
after facing a 45º corner is counted as 1. Then it was calculated the total of turns and also the percentage of the 
number of turns to each side. No significant changes between groups. The percentage is the mean value of the 
score for the group with SD, tested with Kruskal-Wallis (Group B: Sham n=4; EE n=4; STD n=3; EE: enriched 
environment; STD: standard environment). 
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4.3.2 Corridor test 
 
In the corridor test, each side of the food retrieval was counted during the 10 minutes of the 
test along the corridor way. Likewise the corner test, where all the food retrievals were 
counted and the percentage of head turns to the right and left was calculated.  
In the same way as in the corner test, in the corridor test there was no differences in the 
preferable side for food retrieval between sham animals and PT animals, and between EE 
and STD housed animals (Figure 15). 
Thus, PT does not affect the side of food retrieval in the affected animals at 7 days of 
recovery after stroke. 
 
 
 
 
 
 
 
 
 
 
  
Figure 15. Corridor test. Turn biases for food retrieval of rats subjected to PT during 10 min testing. (A) 
Percentage of head turns to the left and (B) to the right. (C) Compares both sides percentage. Each head turns 
towards the pot with sugar pellets of the rat across the corridor is counted as 1. Then it was calculated the total of 
turns and also the percentage of the number of turns to each side. No significant changes between groups. The 
percentage is the mean value of the score for the group with SD, tested with Kruskal-Wallis (Group B: Sham n=4; 
EE n=4; STD n=3; EE: enriched environment; STD: standard environment). 
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4.4 PT affects degradation of β-DG in the SS 
 
As mentioned above, β-DG is mainly found linked to the endothelial cells of vessels in the 
brain (Zaccaria et al., 2001). We confirmed this location (Figure 16A). Basically, in most of 
brain areas, β-DG was found in vessels when stained with a specific antibody 
(Supplementary Figure 1). 
To assess the levels of β-DG in the somatosensory cortex, we employed the Western blot 
technique. Sham, EE and STD animals either in the ipsilateral (Figure 16B) or contralateral 
side (Figure 16C), showed the upper band (43 kDa) basically with the same density. 
Regarding the lower band, the 30 kDa form, a difference between sham and the injured 
animals was noted. The 30 kDa band is essentially not seen in sham group, while in the most 
of the EE and STD animals, we can see the product of the degradation.  
Analyzing the levels of degradation of β-DG, we saw that the levels of the 43 kDa band were 
affected by PT, with no differences between EE and STD housed animals, either in ipsilateral 
or contralateral side (Figures 16D and 16E). 
In the SS of the ipsilateral side, the levels of the 30 kDa product of degradation of β-DG are 
higher in both EE and STD housed animals compared to sham animals (Figure 16F). Hence, 
experimental stroke enhances the degradation of β-DG.  Also, in the EE group more 
degradation is seen, though this difference did not reach statistical significance. Thus, EE 
may stimulate an increased degradation at 7 days of recovery after PT comparing to STD in 
the ipsilateral side. 
Interestingly, in the contralateral side, significant degradation of β-DG is only seen in EE 
housed animals comparing with sham animals (Figure 16G). STD animals showed some 
tendency for that degradation as well, even if it was not statistically significant. 
When we performed immunofluorescence with an antibody against β-DG (Figure 17), we 
found that not only vessels were stained (Figure 17C). 
In summary, β-DG is localized in brain vessels and its degradation into the 30 kDa form 
product in the somatosensory area of both hemispheres is significantly increased after 
experimental stroke, particularly in animals housed in an EE.  
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Figure 16. Expression of beta-dystroglycan in the somatosensory cortex. (A) Beta-dystroglycan 
immunostaining  of the cerebral cortex shows the presence of β-DG mainly in vessels. Scale: 50 μm. (B) 
Expression levels of β-DG 43 kDa and its degradation product 30 kDa in the somatosensory cortex of the 
ipsilateral and (C) contralateral hemisphere of Sham (n=4), EE (n=4) and STD (n=3) at 7 days of recovery after 
PT. Final quantification of both forms of β-DG in the total of 11 animals expressed in arbitrary units (AU). (D) 
Quantification of the levels of 43 kDa form of β-DG in ipsilateral side and (E) contralateral side. No statistically 
significant differences between groups, Sham, EE and STD. (F) Quantification of the levels of 30 kDa form of β-
DG in ipsilateral side and (E) contralateral side. Data displayed as means ± SD and tested with one-way ANOVA 
followed by Bonferroni correction (*: p<0.05). (EE: enriched environment; STD: standard environment; M: 
marker; AU: arbitrary units; β-DG43: beta-dystroglycan 43 kDa; β-DG30: beta-dystroglycan 30 kDa; β-actin: beta 
actin.  
A 
B C 
D E 
F G 
Ipsilateral hemisphere Contralateral hemisphere 
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Figure 17. Expression of beta-dystroglycan surrounding vessels in the somatosensory cortex. Confocal 
images of β-DG (green) with two synaptic proteins (red): PSD-95 (A) and Synaptophysin Ab4 (B). (A) Overall 
view of β-DG co-stained with PSD-95, showing that besides the vessels, there is specific signal surrounding 
the vessels. (B) Higher magnification of β-DG co-stained with Synaptophysin, showing specific dots 
surrounding the vessels. (C) Crop of the upper image to zoom in the image. Arrows: beta-dystroglycan specific 
dots. Scale: 50 µm. 
A 
B 
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4.5 PT affects the enzymatic activity of gelatinases MMP-9 and 
MMP-2 in the SS cortex 
 
As mentioned above, MMPs are known as being brain matrix modulators at delayed stages 
after stroke (Zhao et al., 2006). Therefore, MMPs may have a role in brain plasticity and 
ECM remodeling (Zhao et al., 2006) and that EE may aid in functional recovery after stroke 
by these mechanisms (Madinier et al., 2014). Since the gelatinases MMP-9 and MMP-2 have 
been implicated in cerebral ischemia (Lo et al., 2002) and β-DG was indicated as an 
enzymatic target of MMP-9 (Michaluk et al., 2007), we decided to analyze MMP activity in the 
somatosensory cortex at 7 days of recovery after PT.  
To assess the enzymatic activities of MMP-9 and MMP-2, we employed the Real-time gel 
zymography. Sham, EE and STD animals were analyzed both in the ipsilateral (Figure 18A) 
and contralateral side (Figure 18E). Three bands representing gelatinolytic activity were 
analyzed: the upper band, pro-MMP-9 (92 kDa), the mid band, active-MMP-9 (82 kDa) and 
lower band, MMP-2 (62 kDa). The difference between sham and the injured animals was 
noted in basically all bands in both hemispheres.  
Analyzing the levels of enzymatic activity of pro-MMP-9, in the ipsilateral side, STD animals 
presented a significant enhanced MMP-activity when compared to sham animals (Figure 
18B). However, EE animals did not show a statistical significant difference in the enzymatic 
activity. In the contralateral side, neither EE nor STD showed difference in the pro-MMP-9 
activity when compared to sham, even though the injured animals appeared to have a 
tendency for a higher gelatinolytic activity (Figure 18F). 
Regarding the enzymatic activity of active-MMP-9 in the ipsilateral side of PT, both EE and 
STD animals had a significant higher MMP-9 activity when compared with non-injured 
animals (Figure 18C). When analyzing the contralateral side, only EE animals showed a 
significant enhanced gelatinolytic activity (Figure 18G). 
Finally, MMP-2 enzymatic activity was enhanced in both groups of injured animals compared 
with sham. This result was observed in both hemispheres, ipsi- (Figure 18D) and 
contralateral (Figure 18H).   
It is evident that PT affects the enzymatic activity of gelatinases MMP-9 and MMP-2.  
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Figure 18. Enzymatic activity of gelatinases MMP-9 and MMP-2 in the somatosensory cortex. (A) Enzymatic 
activity levels of pro-MMP-9, active-MMP-9 and MMP-2 in the somatosensory cortex of the ipsilateral and (E) 
contralateral hemisphere of Sham (n=4), EE (n=4) and STD (n=3) at 7 days of recovery after PT. Final 
quantification of MMPs enzymatic activity in the total of 11 animals expressed in arbitrary units (AU). In the 
ipsilateral side, quantification of the enzymatic activity of pro-MMP-9 (B), active-MMP-9 (C) and MMP-2 (D). 
Statistically significant enhanced expression in the injured groups EE and STD when compared with sham. In the 
contralateral side, quantification of the enzymatic activity of pro-MMP-9 (F), active-MMP-9 (G) and MMP-2 (H). 
Only MMP-2 showed enhanced enzymatic activity of both injured groups. Data displayed as means ± SD and 
tested with one-way ANOVA with post hoc multiple comparison test (Tukey test) (*: p<0.05). (EE: enriched 
environment; STD: standard environment; M: marker; AU: arbitrary units; matrix metalloproteinase (MMP)-9: pro-
MMP-9: 92 kDa; act (active)-MMP-9: 82 kDa); MMP-2 (62 kDa). 
Ipsilateral hemisphere 
B 
A 
C D 
Contralateral hemisphere 
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Chapter 5 
Discussion 
 
 
In this study, we show that rats housed in an EE after PT, an ischemic stroke model that 
affects the fore and hind limb motor areas, have an improved neurological recovery 
comparing to the STD housed ones, seen by a tactile/proprioceptive limb placing test. The 
effects of EE in the functional recovery are not due to a decrease in infarct size but correlate 
with degradation of the brain extracellular matrix molecule β-DG, possibly by MMPs. 
The following discussion will be focused on the enhancement of somatosensory functions by 
EE and the possible underlying biological mechanisms.  
 
5.1 PT model: somatosensory neglect  
 
The PT model of stroke is advantageous in studying recovery mechanisms after 
experimental stroke, since the localization and size of the lesion can be controlled very well, 
meaning that it will have little variability among animals (Madinier et al., 2014).  
With this model, plasticity processes affecting various brain regions can be studied – from 
small infarcts induced by single vessel PT occlusions (Sigler et al., 2008) to large brain 
lesions involving entire functional entities such as the SS (Moon et al., 2009; Starkey et al., 
2012). Depending on the size and localization of the lesion, also the recovery is affected and 
the degree of neglect (inability to process and perceive stimuli on one side of the body). 
PT affects the brain leading to deficits in laterality, sensory, motor function and also learning 
(Madinier et al., 2014).  
When we induced the PT lesion, the fore and hind limb motor areas were affected, leaving 
the somatosensory cortex essentially intact (De Ryck et al., 1989; Madinier et al., 2014) 
(Figure 12). The ischemic lesion by PT caused a deficit in a sensorimotor test, the paw 
placement test. As reporter earlier, this test measures the deficit in tactile/proprioceptive 
response when visual stimuli and whisker/snout contact is prevented (De Ryck et al., 1992, 
1989). At 2 days after PT, we saw that the behavioral outcome had a considerable deficit 
when it was tested with PP showing that the tactile/proprioceptive response was affected.  
 66 
Then, the extensive lesion to primary motor cortex caused deficits in fine motor skills due to 
damage of the cortico-spinal tract (CST) and loss of somatosensory functions (Madinier et 
al., 2014). Hence, PT appears to induce a specific somatosensory neglect (De Ryck et al., 
1992, 1989; Madinier et al., 2014).  
 
5.2 EE reverses sensorimotor deficits and dysfunction 
 
Enriched environment induces biological effects in the brain that could account for the 
positive effect in recovery (Wieloch and Nikolich, 2006). We initiated enriched housing at 2 
days after performing experimental stroke, when the infarct can be considered fully matured 
(Madinier et al., 2014).  The rats were kept in EE during 5 days. This time did not affect 
infarct volume size when compared with rats housed in STD cages. Therefore, improved 
performance after EE must be associated with recovery of neuronal functions, connectivity 
and brain plasticity after stroke.  
At the end of the 7 days period studied, the animals housed in the EE cages improved from 
the sensorimotor deficit, assessed by tactile/proprioceptive response that is analyzed by the 
paw placement test. The whisker and visual contact were prevented, so the improvement of 
the behavioral performance is because of the tactile/proprioceptive response. While the 
group of animals housed in EE recovered some of the limb placement response, we 
observed that the changes in the scores between sham animals and EE were not significant; 
in the STD animal group, not even a single rat recovered the limb placement response at 7 
days of recovery after PT. Although the EE housed animal group did not fully recover the fore 
paw placement response, data published earlier this year by our group showed that at 12 
days of recovery in EE, the animals totally recovered the ability of placing the fore paw back 
on the edge of the table (Madinier et al., 2014).  
Regarding the corner and corridor test, animals subjected to PT comparing with sham 
animals at the end of the 7 days study period did not show any difference. Even when 
compared to the baseline percentages, there was no difference before or after experimental 
stroke for all the groups: sham, EE and STD animals. As shown before, these tests are used 
for sensorimotor functional assessment, which has been shown to be reliable for identifying 
and quantifying sensorimotor and postural asymmetries, when there is a unilateral brain 
lesion (Schaar et al., 2010). Even if the corner test has been shown as suitable for 
assessment after experimental stroke, in that study the model used was MCAO, not PT 
(Zhang et al., 2002). There is evidence that the corner and corridor tests take advantage of 
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multiple partial sensory and motor asymmetries associated with nigro/striatal dysfunction 
(Fitzsimmons et al., 2006; Schallert et al., 1982; Zhang et al., 2002). The experimental PT 
stroke model used in our work does not affect either the substantia nigra or the striatum, but 
only the primary motor cortex, unlike the stroke model MCAO. Hence, our results suggest 
that corner and corridor tests are not suitable for the behavioral assessment after ischemic 
stroke lesion that affects specifically the primary motor cortex. 
Therefore, we observed a beneficial effect of EE when using a test of sensory ability and 
proprioception. This suggests that the STD housed animals fail to integrate sensory stimuli to 
trigger a motor response, particularly when visual and whisker/snout stimuli are absent. EE, 
stimulating the sensorimotor network, involved in the sensorimotor response, leads to 
enhancement of cellular and network plasticity. The recovery of tactile sensation and 
proprioception could be envisaged to involve sensorimotor cortex also remote from the lesion 
(Madinier et al., 2014). 
From earlier studies performed in our lab, we know that EE improves cortical plasticity by 
reducing the density of PNNs surrounding PV/GABA neurons in the ECM (Madinier et al., 
2014). In the same line of that study, we aimed to assess which matrix metalloproteinase 
could be involved in those changes of brain extracellular matrix and, in particular, if beta-
dystroglycan, indicated as target for MMP-9, is part of these ECM changes.  
 
5.3 EE enhances degradation of β-DG into a 30 kDa product  
 
Here, we confirm the presence of β-DG mainly in vessels, as shown before (Zaccaria et al., 
2001). Some data show that β-DG is expressed by endothelial cells and astrocytes, both in 
vivo and in vitro. Besides, β-DG is expressed on astrocyte endfeet in all cerebral 
microvessels. These data suggests that a fraction of dystroglycan complex could be the 
principal adhesion receptor system for anchoring astrocytes to the vascular basal lamina 
(Milner et al., 2008).  
We also show that the levels of β-DG 43 kDa form in the SS stay regular between all groups. 
However, we show that PT enhances the degradation of β-DG (into a 30 kDa product). In 
animals of the EE group, the degradation of β-DG is more extensive than the STD group, 
and when compared with no injured animals as well. The degree of β-DG degradation in 
sham animals is very low. This suggests that at 7 days of recovery after stroke, the beta-
dystroglycan enhanced degradation may be involved in the functional recovery of the EE 
housed animals comparing to STD animals, which present a lower β-DG degradation level is 
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lower and worse behavioral outcome. The more extensive degradation of β-DG is seen in 
both brain hemispheres, indicating that not only the ipsilateral hemisphere is involved in the 
functional recovery, but also the contralateral hemisphere. This is suggested by a study that 
showed that functional recovery after one-sided stroke depends in part on the intact 
contralateral cortex. The recovery previously observed after the right-sided motor cortex 
stroke was largely abolished by a second left-sided PT stroke (second stroke) (Bachmann et 
al., 2014). Those results suggest that contralateral cortex contributes to functional recovery 
probably via direct corticospinal fibers to the denervated hemicord as well as via polysynaptic 
routes (Bachmann et al., 2014; Benecke et al., 1991; Jankowska and Edgley, 2006). The 
authors also saw that neurons in the contralateral sensorimotor cortex contralateral to the 
stroke increased their projections into the left hemicord over time. Hence, the study 
suggested that cortical fibres project ipsilaterally as well as contralaterally to the spinal cord, 
and plastic changes occurs on both sides (Bachmann et al., 2014). Another study 
demonstrated an increased size of cutaneous receptive fields in both hemispheres, in 
response to tactile stimulation. Their results show no differences between the sizes of 
receptive fields in the two hemispheres (ipsi and contralateral) in lesioned animals, 
demonstrating that both hemispheres are affected by brain ischemia (Reinecke et al., 2003). 
It is clear from our results and others, that the β-DG expression is manly in the brain vessels, 
however when analyzing confocal images, we saw that there was a specific signal of this 
protein outside the vessels and outside the cells. Surrounding the neurons, where the ECM 
is present, we can see that the protein is present, evident as dots. Indeed, earlier studies 
have shown that β-DG is also present in the post-synaptic elements (Michaluk et al., 2007; 
Zaccaria et al., 2001), suggesting that these dots are related with their previous findings. The 
limited degradation of β-DG after stroke as seen in our Western blots was not depicted in the 
immunostaining. 
Regarding the widely presence of β-DG in brain vessels, it has been shown earlier that 
animals that exercise after brain injury show an increase in the expression of neurotrophic 
factors, which regulate neuronal survival and differentiation, synaptic plasticity, as well as 
angiogenesis in the brain (Endres et al., 2003). A recent study showed that the up regulation 
of Fibroblast Growth Factor-2 (FGF-2), a neurotrophic factor, induced by EE promote 
functional recovery through enhanced angiogenesis after brain injury (Seo et al., 2013). 
Another study showed that with the increased number of brain vessels in a model of rat 
cerebral hypoperfusion, there are changes in the DGC, more specifically in laminin and β-DG 
that are associated with the process of vascular remodeling. Their main finding is that the 
alterations of expressions of these proteins, including β-DG, seem to correlate with 
angiogenesis rather than BBB disruption, supporting the functional recovery (Wappler et al., 
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2011).  
Thus, β-DG is a very widely spread protein in the brain, more evident in the vessels but also 
surrounding the neurons. At 7 days of recovery after stroke, EE leads to an enhancement of 
the degradation of β-DG in the SS in both ipsi- and contralateral hemispheres, which could 
facilitate brain plasticity after experimental stroke and enhance functional recovery.  
 
5.4 PT enhances gelatinolytic activity in the SS cortex 
 
In this work, we show that PT enhances the enzymatic activity of both gelatinases, MMP-9 
and MMP-2. Since there are two types of fractions from the zymography samples, triton-
insoluble fraction (where MMPs are bound to the ECM) and the triton-soluble fraction (MMPs 
in the cytosol), we decided to analyze the triton-insoluble fraction because we are interested 
in studying changes that occur in the ECM at 7 days of recovery after experimental stroke.  
As mentioned before, MMPs have been implicated in different stages of stroke, including 
acute and recovery phases (Chaturvedi and Kaczmarek, 2013; Clark et al., 1997; Planas et 
al., 2001; Rosell and Lo, 2008; Zhao et al., 2006). In the acute phase (the first hours after 
stroke) the MMPs seem to have a deleterious role (Chaturvedi and Kaczmarek, 2013; Rosell 
and Lo, 2008), while in the delayed phases they appear beneficial, mediating dendritic 
plasticity and ECM remodeling of the ischemic brain (Rosell and Lo, 2008; Zhao et al., 2006).  
There are many studies showing the particular expression of MMP-9 and MMP-2 in recovery 
after brain ischemia (Copin and Gasche, 2007; Kurzepa et al., 2014; Planas et al., 2001; 
Zhao et al., 2006). After the discovery of β-DG being a synaptic target of MMP-9 in response 
to enhanced neuronal activity (Michaluk et al., 2007), we aimed to assess if MMP-9 and 
MMP-2 activities change during recovery after PT.  
Here, we show that injured animals, either in EE or STD groups, have a statistically 
significant enhanced enzymatic activity of MMP-9 and MMP-2 when compared with non-
injured sham animals. These results support our data of increased degradation of β-DG at 7 
days of recovery after PT.  
Pro-MMP-9 has a lower expression compared with active-MMP-9 in both hemispheres, 
showing that most of the MMP-9 is actually in the active form in the ECM, which can 
contribute to ECM remodeling and brain plasticity. Since brain plasticity is crucial for recovery 
after stroke, enhanced active-MMP-9 might have a critical role in this functional and 
behavioral recovery.  
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MMP-9 and MMP-2 activity is higher in the ipsilateral side compared to the contralateral side. 
However, analyzing specifically the contralateral active-MMP-9 graph, we saw that only EE 
animals had a significant difference when compared with non-injured animals. The results 
are in line with an increased degradation of β-DG in the contralateral side (Figure 16G). 
Although in this work, we do not have any substantial proof that β-DG is a MMP-9 target, our 
results suggest a good correlation between these proteins.  
Hence, MMPs enzymatic activity is affected by PT and might have a key role for functional 
recovery. The differences in the gelatinolytic activity between EE and STD groups are not 
evident at 7 days of recovery, even if some studies showed the main recovery results due to 
MMPs changes between 7 and 14 days after stroke (Zhao et al., 2006). Additional 
experiments are then needed to establish the role of MMPs at more delayed time of 
recovery. 
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Chapter 6 
Conclusion 
 
 
The PT stroke lesion, which affects the primary motor cortex, the fore and hind paw motor 
areas, is a model to study the mechanisms of somatosensory dysfunction and recovery after 
stroke. 
We show that EE environment does not affect the infarct size of the injured animals. Hence, 
the recovery observed in the behavior is due to neurological functional recovery and not to 
differences in the infarct size.  
The EE housed animals recovered the tactile/proprioceptive paw placement response after 
being 5 days there. Animals housed in the STD cages did not recover any limb placement 
response. Thus, EE has a beneficial effect in the sensorimotor abilities, which was seen by 
the paw placement test. 
When analyzed the corner and corridor tests, we found that because PT does not make a 
lesion in either the substantia nigra or striatum, so those behavioral tests are not suitable to 
analyze any recovery due to the enriched housing. 
From earlier studies, we know that the EE improves cortical plasticity and sensorial 
information processing, by changing the brain ECM. Since β-DG is a target of a matrix 
metalloproteinase, we decided to study the effects of enriched housing on this protein.  
Hence, we confirmed that β-DG is mainly localized in the vessels of the brain but it is also 
expressed surrounding the cells. We suggest that the β-DG localized outside of the vessels it 
is expressed in the ECM, more specifically in the post-synaptic elements.  
We also propose that the β-DG degradation, which leads to a formation of a 30 kDa β-DG 
product, it is enhanced in the EE housed animals more than in the STD ones in both SS ipsi 
and contralateral side, and this may promote cortical plasticity and functional recovery. This 
degradation can be due to the increased activation of the matrix metalloproteinases, seen 
before in other studies after experimental stroke. 
Finally, we saw that MMP-9 and MMP-2 enzymatic activity are enhanced after PT in both 
hemispheres, ipsi- and contralateral. 
Regarding our future work, the role of β-DG in stroke recovery is still unknown, so further 
investigation is needed. Our work was done only at one week of recovery after stroke, so it 
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could be interesting to investigate the levels of degradation of β-DG and gelatinases 
enzymatic activity (MMP-9 and MMP-2) at different time points of recovery after experimental 
stroke. Another possible objective for the future is the analysis of the triton-soluble fraction of 
the zymographic samples, and so being able to study the expression of MMPs in the cytosol.  
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Chapter 8 
Supplementary Data 
 
 
 Weight 
OP Anesthesia Hemisphere 
KL 1500 
LCD Ilumination 
(min) 
OP 
temp 
ºC 
Rose Bengal 
Administration 
15mg RB/kg rat 
and 10 mg RB/1 ml 
salin 
Place of 
Infarct/Lamp 
Infarct 
Size 
  Settings Rectal 
Sham 
EE 
386 10,08 Left x x x 37,3 26 mg in 1.7 ml saline  x 
450 10,49 Left x x x 37,4   x 
Sham 
STD 
349 13,19 Left x x x 37,6 34 mg in 2.2 ml saline  x 
413 13,42 Left x x x 37,4   x 
EE 
358 11,08 Left 4.2C 3000K 20 37,2  
0.5mm relativ 
from bregma, 
+4mm bregma,- 
4mm bregma 
OK++ 
318 13,23 Left 4C 3000K 20 36,8  OK++ 
343 10,57 Left 4C 3000K 20 37,2  OK++ 
358 9,12 Left 4C 3000K 20 37,4 48 mg RB in 3.2 ml saline OK++ 
STD 
374 13,10 Left 4C 3000K 20 37,5  
0.5mm relativ 
from bregma, 
+4mm bregma,- 
4mm bregma 
OK++ 
334 14,07 Left 4C 3000K 20 37,5  OK++ 
352 11,23 Left 4C 3000K 20 36,8 48 mg RB in 3.2 ml saline OK++ 
 
Supplementary Table 1. Study group B: n=11. Sham n=4; EE n=4; STD n=3. Animal settings to perform 
photothrombosis.  
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Supplementary Figure 1. Coronal section stained with beta-dystroglycan. Basically all 
brain section is stained with beta-dystroglycan, showing that it is widely expressed in the brain in 
the vessels. 
